AI & Machine Learning

Diagnostics
Digital Health

Gates Foundation and Wellcome Leap commit $100m to cut stillbirths

The Uzima programme targets a 50% reduction in stillbirth rates across select countries over a decade, led by AI diagnostics and biomarker tools.
The Uzima programme targets a 50% reduction in stillbirth rates across select countries over a decade, led by AI diagnostics and biomarker tools.
The Biotech Times Editorial Team  · 
Digital Health

EliseAI partners with Nextech to embed voice AI in specialty clinics

EliseAI and Nextech are co-developing deeper API integrations to bring agentic voice AI to ophthalmology, dermatology, and orthopaedic practices.
EliseAI and Nextech are co-developing deeper API integrations to bring agentic voice AI to ophthalmology, dermatology, and orthopaedic practices.
The Biotech Times Editorial Team  · 
Digital Health
Diagnostics
Bioinformatics

BioNexus secures exclusive CogniAI licence for Malaysian healthcare AI

BioNexus Gene Lab will build AI document-processing applications for Malaysia's public healthcare digitisation programme under a ten-year exclusive licence.
BioNexus Gene Lab will build AI document-processing applications for Malaysia's public healthcare digitisation programme under a ten-year exclusive licence.
The Biotech Times Editorial Team  · 
Medical Devices
Diagnostics
Digital Health

Spectral AI files NTAP application for DeepView burn-wound system

Spectral AI has applied to CMS for additional Medicare reimbursement for its AI-powered DeepView burn-wound imaging device, cleared by the FDA in May
Spectral AI has applied to CMS for additional Medicare reimbursement for its AI-powered DeepView burn-wound imaging device, cleared by the FDA in May
The Biotech Times Editorial Team  · 
Biotech
Diagnostics
Bioinformatics

Holobiome and Radicle Science launch 6,000-person gut-brain trial

The ARPA-H-backed GUT-FEELINGS study will test 19 prebiotic formulas against anxiety outcomes across 6,000 participants, with initial results expected in late
The ARPA-H-backed GUT-FEELINGS study will test 19 prebiotic formulas against anxiety outcomes across 6,000 participants, with initial results expected in late
The Biotech Times Editorial Team  · 
Pharmaceuticals
Genomics
Bioprocessing

UAE biopharma push targets double-digit precision medicine growth

A Frost & Sullivan report for World Health Expo projects over 10% annual precision medicine growth in the Middle East over the next five to seven
A Frost & Sullivan report for World Health Expo projects over 10% annual precision medicine growth in the Middle East over the next five to seven
The Biotech Times Editorial Team  · 
Biotech
Bioinformatics

Bexorg wins up to $28.3m ARPA-H award to extend human brain perfusion

The New Haven CNS platform company will use the 36-month grant to push its BrainEx system from 24-hour to two-week intact human
The New Haven CNS platform company will use the 36-month grant to push its BrainEx system from 24-hour to two-week intact human
The Biotech Times Editorial Team  · 
Biologics
Cell & Gene Therapy

Candel reports durable immune remodelling data for aglatimagene

AI-enabled digital pathology shows aglatimagene drove sustained lymphocyte-tumour engagement more than two years after treatment in a phase 3 prostate cancer trial.
AI-enabled digital pathology shows aglatimagene drove sustained lymphocyte-tumour engagement more than two years after treatment in a phase 3 prostate cancer trial.
The Biotech Times Editorial Team  · 
Medical Devices
Digital Health
Diagnostics

Ceribell wins FDA clearance for qEEG trending on its AI platform

Ceribell's 510(k)-cleared software adds three quantitative EEG tools to its point-of-care platform, covering patients from premature neonates to adult ICU
Ceribell's 510(k)-cleared software adds three quantitative EEG tools to its point-of-care platform, covering patients from premature neonates to adult ICU
The Biotech Times Editorial Team  · 
Digital Health
Diagnostics

DarDoc launches truesight beta AI layer inside Lifestyle Rx platform

Dubai-based DarDoc has launched a machine learning intelligence layer that proactively surfaces patient context between appointments, available to Lifestyle Rx members.
Dubai-based DarDoc has launched a machine learning intelligence layer that proactively surfaces patient context between appointments, available to Lifestyle Rx members.
The Biotech Times Editorial Team  · 
Medical Devices
Diagnostics
Digital Health

CapsoVision wins FDA clearance for AI Highlights capsule endoscopy tool

CapsoVision's AI-assisted reading tool for its CapsoCam Plus system has received FDA clearance, following an earlier EU launch under MDR.
CapsoVision's AI-assisted reading tool for its CapsoCam Plus system has received FDA clearance, following an earlier EU launch under MDR.
The Biotech Times Editorial Team  · 
Digital Health

Ingenio Care launches AI-enabled national healthcare marketplace

The Illinois-based digital health company says its marketplace lists over 7.5 million US providers with CMS pricing and quality data.
The Illinois-based digital health company says its marketplace lists over 7.5 million US providers with CMS pricing and quality data.
The Biotech Times Editorial Team  · 
Biologics
Pharmaceuticals

Absci plans Phase 2 STORYLINE trial of ABS-201 for endometriosis

Absci will launch a global, placebo-controlled Phase 2 study of its AI-designed anti-PRLR antibody ABS-201 in endometriosis patients from mid-2027.
Absci will launch a global, placebo-controlled Phase 2 study of its AI-designed anti-PRLR antibody ABS-201 in endometriosis patients from mid-2027.
The Biotech Times Editorial Team  · 
Medical Devices
Digital Health
Diagnostics

Firefly and NeuroSigma partner to distribute FDA-cleared ADHD device

Firefly Neuroscience will introduce NeuroSigma's Monarch eTNS sleep-worn neurostimulator to its US clinician network as a non-drug ADHD option for children.
Firefly Neuroscience will introduce NeuroSigma's Monarch eTNS sleep-worn neurostimulator to its US clinician network as a non-drug ADHD option for children.
The Biotech Times Editorial Team  · 
Digital Health

Knowtex named prime awardee on VA's $775m ambient scribe contract

The San Francisco AI healthcare company is one of only two prime awardees on the VA's five-year enterprise ambient scribe contract worth up
The San Francisco AI healthcare company is one of only two prime awardees on the VA's five-year enterprise ambient scribe contract worth up
The Biotech Times Editorial Team  · 
Biologics
Cell & Gene Therapy
Pharmaceuticals

Transgene reports 100% DFS at 41 months for TG4050 HNSCC vaccine

Transgene's personalised neoantigen vaccine TG4050 maintained 100% disease-free survival at over three years in resected head and neck cancer, with Phase 2 topline
Transgene's personalised neoantigen vaccine TG4050 maintained 100% disease-free survival at over three years in resected head and neck cancer, with Phase 2 topline
The Biotech Times Editorial Team  · 
Diagnostics
Digital Health

PhAST Corp. wins FDA clearance for rapid blood culture AST panel

PhAST Corp.'s Gram-negative panel delivers antimicrobial susceptibility results in under 2.5 hours directly from positive blood cultures, cutting a typical 24-48
PhAST Corp.'s Gram-negative panel delivers antimicrobial susceptibility results in under 2.5 hours directly from positive blood cultures, cutting a typical 24-48
The Biotech Times Editorial Team  · 
Biologics
Bioinformatics

Envisagenics and Boehringer Ingelheim in $1bn RNA splicing deal

Envisagenics' AI-powered SpliceCore platform will supply tumour-specific targets to Boehringer across ADC, T-cell engager and multispecific antibody programmes.
Envisagenics' AI-powered SpliceCore platform will supply tumour-specific targets to Boehringer across ADC, T-cell engager and multispecific antibody programmes.
The Biotech Times Editorial Team  · 
Diagnostics
Digital Health
Medical Devices

Spectral AI showcases DeepView burn diagnostic at SRBC

Spectral AI displayed its FDA-cleared DeepView multispectral imaging system at the Southern Regional Burn Conference, with two KOL presentations backing its clinical
Spectral AI displayed its FDA-cleared DeepView multispectral imaging system at the Southern Regional Burn Conference, with two KOL presentations backing its clinical
The Biotech Times Editorial Team  · 
Pharmaceuticals
Diagnostics
Bioinformatics

Roche opens Boston CVRM hub at Harvard campus as part of $50bn US push

Roche and Genentech have opened a 95,000 sq m Innovation Center in Allston, Boston, housing up to 500 staff focused on cardiovascular, renal and
Roche and Genentech have opened a 95,000 sq m Innovation Center in Allston, Boston, housing up to 500 staff focused on cardiovascular, renal and
The Biotech Times Editorial Team  · 
Subscribe to AI & Machine Learning